Literature DB >> 24624448

Validity of the MAGIC study: sufficient for recommendations?

Katrin Bauer, Franz Porzsolt, Doris Henne-Bruns.   

Abstract

According to the recommendations of the German S3 guideline, perioperative chemotherapy is an integral part of the treatment concept for advanced gastric cancer. The leading trial which examined the effects of perioperative chemotherapy is the MAGIC study. An examination of the validity of this study with a standardized method revealed shortcomings in the six areas: design, protocol, selection of patients, randomization / homogeneity of patient groups, quality of the surgical care and the statistical evaluation. These shortcomings and their influence on the study results are described in this paper to reveal the importance of these effects for discussion in guidelines committees.

Entities:  

Mesh:

Year:  2013        PMID: 24624448

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  3 in total

1.  Can perioperative chemotherapy for advanced gastric cancer be recommended on the basis of current research? A critical analysis.

Authors:  Katrin Bauer; Franz Porzsolt; Doris Henne-Bruns
Journal:  J Gastric Cancer       Date:  2014-03-31       Impact factor: 3.720

2.  The prognostic value of irradiated lung volumes on the prediction of intra-/ post-operative mortality in patients after neoadjuvant radiochemotherapy for esophageal cancer. A retrospective multicenter study.

Authors:  Philipp Günther Kup; Carsten Nieder; Hans Geinitz; Christoph Henkenberens; Angela Besserer; Markus Oechsner; Sabine Schill; Ralph Mücke; Vera Scherer; Stephanie E Combs; Irenäus A Adamietz; Khashayar Fakhrian
Journal:  J Cancer       Date:  2015-01-20       Impact factor: 4.207

3.  Perioperative chemotherapy for advanced gastric cancer - results from a tertiary-care hospital in Germany.

Authors:  Katrin Bauer; Giulia Manzini; Doris Henne-Bruns; Peter Buechler
Journal:  World J Gastrointest Oncol       Date:  2020-05-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.